Therefore, an increase in the PKM1/PKM2 ratio and the activation of hepatocyte nuclear factor 4 alpha (HNF-4α) to induce hepatoma differentiation and suppress cancer progression using oroxylin A could be therapeutically relevant in liver cancer [173]. This evidence concerns the gene HNF4A and cancer.